The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer

A randomized phase III trial of denosumab versus zoledronic acid in patients with bone metastases from castration-resistant prostate cancer.

(2017) K. Fizazi et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating Tumor Cells and Circulating Tumor DNA

(2011) Catherine Alix-Panabières et al.   Annual Review of Medicine

Phase II Study of Abiraterone Acetate in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Displaying Bone Flare Discordant with Serologic Response

(2011) C. J. Ryan et al.   CLINICAL CANCER RESEARCH

Circulating tumor cells in prostate cancer: A potential surrogate marker of survival

(2011) Jérôme Doyen et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

717 EVALUATION OF PROSTATE-SPECIFIC ANTIGEN KINETICS DURING ZOLEDRONIC ACID THERAPY FOR BONE METASTASES IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER

(2011) Fred Saad et al.   JOURNAL OF UROLOGY

External quality assurance of circulating tumor cell enumeration using the CellSearch® system: A feasibility study

(2010) Jaco Kraan et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Significant and Sustained Antitumor Activity in Post-Docetaxel, Castration-Resistant Prostate Cancer With the CYP17 Inhibitor Abiraterone Acetate

(2010) Alison H.M. Reid et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial

(2010) Rebecca Aft et al.   LANCET ONCOLOGY

Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer

(2010) S. L. Stott et al.   Science Translational Medicine

Circulating tumour cells in cancer patients: challenges and perspectives

(2010) Klaus Pantel et al.   TRENDS IN MOLECULAR MEDICINE

Zoledronic Acid Improves Clinical Outcomes When Administered Before Onset of Bone Pain in Patients With Prostate Cancer

(2010) Fred Saad et al.   UROLOGY

Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study

(2009) P Eschwège et al.   BRITISH JOURNAL OF CANCER

Biomarkers for prostate cancer

(2009) Eddy S. Leman et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Perioperative Activation of Disseminated Tumor Cells in Bone Marrow of Patients With Prostate Cancer

(2009) Dorothea Weckermann et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data

(2009) Howard I Scher et al.   LANCET ONCOLOGY

Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer

(2009) Matthew R. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

Circulating Tumor Cells: Evolving Evidence and Future Challenges

(2009) E. Dotan et al.   ONCOLOGIST

Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience

(2008) D. Olmos et al.   ANNALS OF ONCOLOGY

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

(2008) Sendurai A. Mani et al.   CELL

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

(2008) J. S. de Bono et al.   CLINICAL CANCER RESEARCH

Prognostic Significance of Disseminated Tumor Cells in the Bone Marrow of Prostate Cancer Patients Treated With Neoadjuvant Hormone Treatment

(2008) Jens Köllermann et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating Tumor Cells in Peripheral Blood Samples From Patients With Increased Serum Prostate Specific Antigen: Initial Results in Early Prostate Cancer

(2008) John W. Davis et al.   JOURNAL OF UROLOGY

Studies of prostate-cancer mortality: caution advised

(2008) Ruth Etzioni et al.   LANCET ONCOLOGY